Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample
Description
CONCLUSION: COVID-19 patients with systemic sclerosis had worse outcomes (i.e. higher composite endpoint of major adverse events) than those without systemic sclerosis. Further studies are needed to establish a better understanding of the
